• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

LY2157299

CAS No. 700874-72-2

LY2157299 ( Galunisertib | LY-2157299 | LY 2157299 )

产品货号. M15689 CAS No. 700874-72-2

LY2157299 (Galunisertib) 是一种有效、特异性的 TGF-β 受体 I 激酶 ((TGF-βRI)) 抑制剂,IC50 为 56 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥324 有现货
10MG ¥405 有现货
50MG ¥996 有现货
100MG ¥1604 有现货
200MG ¥2414 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    LY2157299
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    LY2157299 (Galunisertib) 是一种有效、特异性的 TGF-β 受体 I 激酶 ((TGF-βRI)) 抑制剂,IC50 为 56 nM。
  • 产品描述
    LY2157299 (Galunisertib) is a potent, specific inhibitor of TGF-β receptor I kinase ((TGF-βRI) with IC50 of 56 nM; inhibits TGF-β-mediated SMAD2 activation and hematopoietic suppression in primary hematopoietic stem cells in a dose-dependent manner, stimulates hematopoiesis from primary MDS bone marrow specimens; ameliorates anemia in a TGF-β overexpressing transgenic mouse model of bone marrow failure; displays significant antitumor activity against both Calu6 and MX1 xenografts in mice.Blood Cancer Phase 3 Clinical(In Vitro):Galunisertib (LY2157299) (0.1, 1, 10, and 100 μM) displays a slight dose-dependent potentiation of Bay 43-9006 in SK-Sora, HepG2, and Hep3B cell lines but not in JHH6, SK-HEP1, and HuH7 cell lines.(In Vivo):Human xenografts Calu6 (non-small cell lung cancer) and MX1 (breast cancer) are implanted subcutaneously in nude mice. After oral administration of 75 mg/kg, Galunisertib (LY2157299) induces a 70% decrease in pSmad for both types of cell lines. The time at which pSmad recovered 80% of baseline is approximately 6 h after administration.
  • 体外实验
    Galunisertib (LY2157299) (0.1, 1, 10, and 100 μM) displays a slight dose-dependent potentiation of Bay 43-9006 in SK-Sora, HepG2, and Hep3B cell lines but not in JHH6, SK-HEP1, and HuH7 cell lines.
  • 体内实验
    Human xenografts Calu6 (non-small cell lung cancer) and MX1 (breast cancer) are implanted subcutaneously in nude mice. After oral administration of 75 mg/kg, Galunisertib (LY2157299) induces a 70% decrease in pSmad for both types of cell lines. The time at which pSmad recovered 80% of baseline is approximately 6 h after administration.
  • 同义词
    Galunisertib | LY-2157299 | LY 2157299
  • 通路
    TGF-beta/Smad
  • 靶点
    TGFBR
  • 受体
    TβRI
  • 研究领域
    Cancer
  • 适应症
    Blood cancer

化学信息

  • CAS Number
    700874-72-2
  • 分子量
    369.4192
  • 分子式
    C22H19N5O
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: ≥ 47 mg/mL
  • SMILES
    O=C(C1=CC=C2N=CC=C(C3=C(CCC4)N4N=C3C5=NC(C)=CC=C5)C2=C1)N
  • 化学全称
    6-Quinolinecarboxamide, 4-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Zhou L, et al. Cancer Res. 2011 Feb 1;71(3):955-63. 2. Yoon JH, et al. EMBO Mol Med. 2013 Nov;5(11):1720-39. 3. Bhola NE, et al. J Clin Invest. 2013 Mar;123(3):1348-58. 4. Rodon J, et al. Clin Cancer Res. 2015 Feb 1;21(3):553-60.
产品手册
关联产品
  • SIS3

    选择性Smad3抑制剂;减弱 TGF-β1 依赖性 Smad3 磷酸化和 DNA 结合。

  • SB-431542

    SB-431542 是一种有效的、特异性的 TGF-β I 型受体 (ALK5) 抑制剂,IC50 为 94 nM。

  • San78-130

    San78-130 是一种有效的选择性激活素受体样激酶 1 (ALK1) 抑制剂,IC50 为 62 nM。